Limonin Exhibits Anti-Inflammatory Effects by Inhibiting mTORC1 and Mitochondrial Reactive Oxygen Species in Psoriatic-like Skin Inflammation
Antioxidants · 16.12.2024 · 13 (12) · 1541
DOI: 10.3390/antiox13121541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 16.12.2024. Verfasst von Seung Taek Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Jeonbuk National University Medical School, Jeonju 54907, Republic of Korea. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Education (MOE), Fund of Biomedical Research Institute, Jeonbuk National University Hospital.
Abstract (Originalsprache)
Psoriasis is a chronic inflammatory skin disorder characterized by abnormal immune responses and keratinocyte hyperproliferation. Limonin, a bioactive compound found in citrus fruits, has anti-inflammatory properties in various models; however, its effects on psoriasis are not fully understood. We investigated the therapeutic potential of limonin in a 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced psoriasis mouse model. Mice were treated with TPA to induce psoriasis-like skin lesions, followed by intraperitoneal administration of limonin (200 or 400 μg/mouse) for six days. The results showed that limonin improved psoriasis-related symptoms in a psoriasis-like mouse model by suppressing the mRNA expression of pro-inflammatory cytokines and inflammation-related antimicrobial peptides and regulating the expansion of myeloid cells and T cells. Specifically, limonin reduced glucose uptake and oxidative phosphorylation to shift the metabolic program in the inflamed skin cells of psoriasis-like mice. Limonin activates AMPK and proteins related to mTOR inhibition, thereby suppressing the mTOR signaling pathway. It also inhibits mitochondrial mass and mitochondrial ROS production, thereby preventing the development of dysfunctional mitochondria in inflamed skin cells. Overall, limonin modulates key immune responses and metabolic pathways related to inflammation and mitochondrial health in psoriasis. Therefore, it is a promising natural candidate for the treatment of psoriasis and various inflammatory skin diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Jeonbuk National University Medical School, Jeonju 54907, Republic of Korea.
- Department of Biochemistry, Chungbuk National University, Cheongju 28644, Republic of Korea.
- Biomedical Research Institute of Jeonbuk National University Hospital, Institute for Medical Sciences, Jeonbuk National University, Jeonju 54907, Republic of Korea.
ORCID-Profile: Seung Taek Lee, Jong Yeong Lee
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of Education (MOE)
- Fund of Biomedical Research Institute, Jeonbuk National University Hospital
- the Center for University-wide Research Facilities (CURF) at Jeonbuk National University
Zitieren
APA
Lee, S. T., Lee, J. Y., Kim, H. E., Park, J. Y., & Choi, J. K. (2024). Limonin Exhibits Anti-Inflammatory Effects by Inhibiting mTORC1 and Mitochondrial Reactive Oxygen Species in Psoriatic-like Skin Inflammation. Antioxidants, 13(12), 1541. https://doi.org/10.3390/antiox13121541
Vancouver
Lee ST, Lee JY, Kim HE, Park JY, Choi JK. Limonin Exhibits Anti-Inflammatory Effects by Inhibiting mTORC1 and Mitochondrial Reactive Oxygen Species in Psoriatic-like Skin Inflammation. Antioxidants. 2024;13(12):1541. doi:10.3390/antiox13121541
BibTeX
@article{Lee2024,
author = {Lee, Seung Taek and Lee, Jong Yeong and Kim, Ha Eun and Park, Jun-Young and Choi, Jin Kyeong},
title = {Limonin Exhibits Anti-Inflammatory Effects by Inhibiting mTORC1 and Mitochondrial Reactive Oxygen Species in Psoriatic-like Skin Inflammation},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {12},
pages = {1541},
doi = {10.3390/antiox13121541}
}
EUVIMED